OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes
Anandan Palani, Andrea R. Nawrocki, Federica Orvieto, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 8, pp. 1248-1254
Open Access | Times Cited: 7
Anandan Palani, Andrea R. Nawrocki, Federica Orvieto, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 8, pp. 1248-1254
Open Access | Times Cited: 7
Showing 7 citing articles:
The molecular pharmacology of glucagon agonists in diabetes and obesity
Aaron Novikoff, Timo D. Müller
Peptides (2023) Vol. 165, pp. 171003-171003
Open Access | Times Cited: 40
Aaron Novikoff, Timo D. Müller
Peptides (2023) Vol. 165, pp. 171003-171003
Open Access | Times Cited: 40
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
Robert M. Gutgesell, Rubén Nogueiras, Matthias H. Tschöp, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1069-1084
Open Access | Times Cited: 13
Robert M. Gutgesell, Rubén Nogueiras, Matthias H. Tschöp, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1069-1084
Open Access | Times Cited: 13
Approved and Emerging Hormone-Based Anti-Obesity Medications: A Review Article
Wael R. Sidrak, Sanjay Kalra, Atul Kalhan
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 5, pp. 445-460
Open Access | Times Cited: 5
Wael R. Sidrak, Sanjay Kalra, Atul Kalhan
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 5, pp. 445-460
Open Access | Times Cited: 5
Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation
Beste Mutlu, Kfir Sharabi, Jee Hyung Sohn, et al.
Cell chemical biology (2024)
Closed Access | Times Cited: 1
Beste Mutlu, Kfir Sharabi, Jee Hyung Sohn, et al.
Cell chemical biology (2024)
Closed Access | Times Cited: 1
Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and Obesity
Chunhui Huang, Anandan Palani, Zhiqiang Yang, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 8, pp. 1255-1261
Open Access | Times Cited: 3
Chunhui Huang, Anandan Palani, Zhiqiang Yang, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 8, pp. 1255-1261
Open Access | Times Cited: 3
Design, Structure–Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor Agonists
Jonathon R. Sawyer, Joseph Audie, Jon Swanson, et al.
Molecules (2024) Vol. 30, Iss. 1, pp. 12-12
Open Access
Jonathon R. Sawyer, Joseph Audie, Jon Swanson, et al.
Molecules (2024) Vol. 30, Iss. 1, pp. 12-12
Open Access
Multi‐target Peptides for the Treatment of Metabolic Diseases
Martin Bossart, Gerhard Heßler
(2024), pp. 269-288
Closed Access
Martin Bossart, Gerhard Heßler
(2024), pp. 269-288
Closed Access
